CMS approved a New Technology Add-on Payment for Bayesian Health's FDA cleared continuous AI sepsis monitor, creating Medicare payment support for health systems running the platform.
Our readThis is the rarest event in this index, which is an AI tool acquiring a reimbursement pathway rather than only a clearance. Clearance establishes that a product may be used and says nothing about who pays for it, and the absence of a payment mechanism is the reason most cleared clinical AI stalls after the pilot. An NTAP moves the conversation from the innovation budget to the operating one.